Libertas is proud to announce that Drug Target Insights has been included in the 2012 Australian Research Council’s Excellence in Research for Australia (ERA) List.
The ERA list assesses the quality of research to be used in universities across Australia. This year’s list has over 22,000 recommended journals for use within Australia’s top universities and takes around 2 years to compile.
Only the top Australian universities are eligible to submit their published data to the ERA initiative. Having Drug Target Insights included in the ERA list shows its popularity with Australian researchers and the high quality of papers published in Drug Target Insights.
Also included in the ERA 2012 List were:
Analytical Chemistry Insights
Biomarker Insights
Cancer Informatics
Evolutionary Bioinformatics
Environmental Health Insights
Gene Regulation and Systems Biology
Integrative Medicine Insights
Substance Abuse: Research and Treatment
Visit the Drug Target Insights homepage and view the Editor in Chief’s call for papers
Posts
